Article
The effect of genetic polymorphisms in STIM1 and ORAI1 on erythropoietin resistance in Egyptian patients with end-stage renal disease.
Clinica chimica acta; international journal of clinical chemistry - 1 Jan 2025
Gomaa Azza A E, Zeid Amany M A, Nagy Ibrahim M, Zahran Ahmed M
Abstract excerpt
Chronic renal failure (CRF) is an incurable disease with unique challenges. Anemia is a frequent complication affecting dialysis patients. Erythropoietin (EPO) is used to treat anemia, but a poor response may result. We investigated genetic polymorphisms of store-operated calcium channel (SOC) signaling, an important erythropoietin-activated pathway that may induce EPO resistance in patients with renal failure. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
